| Revenue Information |
Note
10 – Revenue Information
Revenue
by product lines was as follows:
| |
|
Three Months Ended |
|
|
Six Months Ended |
|
| |
|
June 30, |
|
|
June 30, |
|
| Product Line |
|
2019 |
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
| MicroParticle Catalyzed Biosensor (“MPC”) |
|
$ |
65,344 |
|
|
$ |
106,680 |
|
|
$ |
88,664 |
|
|
$ |
125,630 |
|
| Particle ImmunoFiltration Assay (“PIFA”) |
|
|
304,658 |
|
|
|
356,082 |
|
|
|
880,973 |
|
|
|
616,066 |
|
| Rapid Enzymatic Assay (“REA”) |
|
|
85,000 |
|
|
|
45,100 |
|
|
|
85,000 |
|
|
|
55,000 |
|
| Other |
|
|
9,511 |
|
|
|
18,739 |
|
|
|
21,997 |
|
|
|
32,380 |
|
| Total Revenue |
|
$ |
464,513 |
|
|
$ |
526,601 |
|
|
$ |
1,076,634 |
|
|
$ |
829,076 |
|
The
total revenue by geographic area determined based on the location of the customers was as follows:
| |
|
Three Months Ended |
|
|
Six Months Ended |
|
| |
|
June 30, |
|
|
June 30, |
|
| Geographic Region |
|
2019 |
|
|
2018 |
|
|
2019 |
|
|
2018 |
|
| United States |
|
$ |
447,013 |
|
|
$ |
462,383 |
|
|
$ |
1,059,134 |
|
|
$ |
757,116 |
|
| Rest of World |
|
|
17,500 |
|
|
|
64,218 |
|
|
|
17,500 |
|
|
|
71,960 |
|
| Total Revenue |
|
$ |
464,513 |
|
|
$ |
526,601 |
|
|
$ |
1,076,634 |
|
|
$ |
829,076 |
|
The
Company had long-lived assets totaling $13,097 and $14,294 located in the People’s Republic of China and $278,791 and $312,573
located in the United States as of June 30, 2019 and December 31, 2018, respectively.
|